Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HDAC inhibition: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| Histone Acetylation | upregulates | process | 0.85 |
| microglial homeostasis | regulates | process | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| 16837598 | results in | paper | 0.90 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Gut-BBB Axis: Tributyrin/Butyrate HDAC Inhibition Epigenetic | 0.712 | - | Blood-brain barrier permeability changes |
| Direct neuronal HDAC inhibition is unlikely to mediate thera | 0.560 | neurodegeneration | Do physiological concentrations of SCFAs |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-01 | 13 hypotheses Top: 0.907
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning HDAC inhibition in their description or question text
No additional research found